Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
REGN5093-M114
i
Other names:
REGN5093-M114
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Regeneron
Drug class:
Tubulin inhibitor, c-MET-targeted antibody-drug conjugate
Related drugs:
‹
albumin-bound paclitaxel (67)
A166 (6)
JNJ-8177 (3)
micellar paclitaxel (3)
XMT-1660 (3)
vinblastine (3)
HZX-02-059 (2)
AR160 (2)
DJ 927 (2)
ACT-903 (1)
ADC2122 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
YH012 (1)
hIMB1636-MMAE (1)
ABT-751 (0)
BMS-986148 (0)
CBP-1018 (0)
paclitaxel polymeric micelle formulation (0)
paclitaxel liposomal (0)
liposomal paclitaxel (0)
paclitaxel nanoformulation (0)
paclitaxel-hyaluronic acid conjugate (0)
paclitaxel poliglumex (0)
bisphosphonate bound paclitaxel (0)
FID-007 (0)
CB 3304 (0)
BAY 59-8862 (0)
QR 207 (0)
ANG1005 (0)
ABBV-399 (11)
HRA00129-C004 (3)
SHR-A1403 (3)
ABBV-400 (3)
BYON3521 (2)
DM004 (2)
DM005 (2)
MYTX-011 (2)
TR1801-ADC (2)
AZD9592 (2)
RC108 (0)
albumin-bound paclitaxel (67)
A166 (6)
JNJ-8177 (3)
micellar paclitaxel (3)
XMT-1660 (3)
vinblastine (3)
HZX-02-059 (2)
AR160 (2)
DJ 927 (2)
ACT-903 (1)
ADC2122 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
YH012 (1)
hIMB1636-MMAE (1)
ABT-751 (0)
BMS-986148 (0)
CBP-1018 (0)
paclitaxel polymeric micelle formulation (0)
paclitaxel liposomal (0)
liposomal paclitaxel (0)
paclitaxel nanoformulation (0)
paclitaxel-hyaluronic acid conjugate (0)
paclitaxel poliglumex (0)
bisphosphonate bound paclitaxel (0)
FID-007 (0)
CB 3304 (0)
BAY 59-8862 (0)
QR 207 (0)
ANG1005 (0)
ABBV-399 (11)
HRA00129-C004 (3)
SHR-A1403 (3)
ABBV-400 (3)
BYON3521 (2)
DM004 (2)
DM005 (2)
MYTX-011 (2)
TR1801-ADC (2)
AZD9592 (2)
RC108 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
MET expression
Non Small Cell Lung Cancer
MET expression
Non Small Cell Lung Cancer
REGN5093-M114
Sensitive: D – Preclinical
REGN5093-M114
Sensitive
:
D
REGN5093-M114
Sensitive: D – Preclinical
REGN5093-M114
Sensitive
:
D
EGFR mutation + PTEN deletion
Non Small Cell Lung Cancer
EGFR mutation + PTEN deletion
Non Small Cell Lung Cancer
osimertinib + savolitinib + REGN5093-M114
Sensitive: D – Preclinical
osimertinib + savolitinib + REGN5093-M114
Sensitive
:
D
osimertinib + savolitinib + REGN5093-M114
Sensitive: D – Preclinical
osimertinib + savolitinib + REGN5093-M114
Sensitive
:
D
MET Y1230C
Non Small Cell Lung Cancer
MET Y1230C
Non Small Cell Lung Cancer
osimertinib + savolitinib + REGN5093-M114
Sensitive: D – Preclinical
osimertinib + savolitinib + REGN5093-M114
Sensitive
:
D
osimertinib + savolitinib + REGN5093-M114
Sensitive: D – Preclinical
osimertinib + savolitinib + REGN5093-M114
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login